Implementation of the treatable traits approach in a regional clinic: Improving health outcomes in adults with bronchiectasis. [PDF]
Krieg KE, Lee AL, Dwyer TJ, McKeough ZJ.
europepmc +1 more source
Hypertonic saline in non-cystic fibrosis bronchiectasis (Hyper-BRONCHI): an updated systematic review and meta-analysis. [PDF]
Nguyen N +8 more
europepmc +1 more source
The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap. [PDF]
Menzella F +3 more
europepmc +1 more source
Development and internal validation of a LASSO-based clinical prediction model for nontuberculous mycobacterial pulmonary disease versus pulmonary tuberculosis. [PDF]
Liu H +6 more
europepmc +1 more source
Greater disease severity in adults with paediatric-onset <i>versus</i> adult-onset bronchiectasis: a multicentre EMBARC registry study. [PDF]
Khalaili L +12 more
europepmc +1 more source
AI based prediction of severe exacerbation in Asian bronchiectasis patients using the KMBARC registry. [PDF]
Yang B +10 more
europepmc +1 more source
Related searches:
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
New England Journal of Medicine, 2020Francesco B Blasi +2 more
exaly

